menu search

IRON / Disc Medicine: Soaring On EPP Data Release, Reality May Bite On Limited Market Opportunity

Disc Medicine: Soaring On EPP Data Release, Reality May Bite On Limited Market Opportunity
Disc Medicine stock has shown outstanding growth since the company joined the Nasdaq in December last year, gaining nearly 250%. The company released data today from a Phase 2 study of lead candidate Bitopertin -acquired from Roche - in the rare disease Erythropoietic Porphyria. EPP patients suffer skin damaging skin conditions when exposed to sunlight - results from the BEACON study demonstrated marked and encouraging improvements. Read More
Posted: Jun 9 2023, 15:32
Author Name: Seeking Alpha
Views: 102483

IRON News  

Disc Medicine to Participate in Upcoming Investor Conferences

By GlobeNewsWire
August 30, 2023

Disc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the disco more_horizontal

Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why

By Zacks Investment Research
August 11, 2023

Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why

Disc Medicine, Inc. (IRON) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from more_horizontal

Here's Why Disc Medicine, Inc. (IRON) Is a Great 'Buy the Bottom' Stock Now

By Zacks Investment Research
July 25, 2023

Here's Why Disc Medicine, Inc. (IRON) Is a Great 'Buy the Bottom' Stock Now

Disc Medicine, Inc. (IRON) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with a more_horizontal

Disc Medicine: Soaring On EPP Data Release, Reality May Bite On Limited Market Opportunity

By Seeking Alpha
June 9, 2023

Disc Medicine: Soaring On EPP Data Release, Reality May Bite On Limited Market Opportunity

Disc Medicine stock has shown outstanding growth since the company joined the Nasdaq in December last year, gaining nearly 250%. The company released more_horizontal

Why Shares of Disc Medicine Opco Climbed This Week

By The Motley Fool
June 1, 2023

Why Shares of Disc Medicine Opco Climbed This Week

Disc Medicine is a clinical-stage biopharmaceutical company specializing in treating blood disorders. The company's lead therapy, bitopertin, is in ph more_horizontal

Disc Medicine, Inc. (IRON) is on the Move, Here's Why the Trend Could be Sustainable

By Zacks Investment Research
May 5, 2023

Disc Medicine, Inc. (IRON) is on the Move, Here's Why the Trend Could be Sustainable

Disc Medicine, Inc. (IRON) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the m more_horizontal

Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why

By Zacks Investment Research
April 19, 2023

Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, Disc Medicine, Inc. (IRON) could be a great choice. It is one more_horizontal


Search within

Pages Search Results: